scispace - formally typeset
F

Fred Kironde

Researcher at Islamic University in Uganda

Publications -  61
Citations -  2411

Fred Kironde is an academic researcher from Islamic University in Uganda. The author has contributed to research in topics: Plasmodium falciparum & Malaria. The author has an hindex of 26, co-authored 60 publications receiving 2214 citations. Previous affiliations of Fred Kironde include St. Augustine International University & San Francisco General Hospital.

Papers
More filters
Journal ArticleDOI

Polymorphisms in Plasmodium falciparum chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, +67 more
TL;DR: Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.
Journal ArticleDOI

A molecular link between malaria and Epstein-Barr virus reactivation.

TL;DR: This is the first report to show that a microbial protein can drive a latently infected B cell into EBV replication and suggest that P. falciparum antigens such as CIDR1α can directly induce EBV reactivation during malaria infection that may increase the risk of BL development for children living in malaria-endemic areas.
Journal ArticleDOI

Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1.

TL;DR: HS and the previously identified HS-like GAG on uninfected erythrocytes may act as coreceptors in endothelial and ERYthrocyte binding of rosetting parasites, causing excessive sequestration of both pRBCs and RBCs.
Journal ArticleDOI

PfEMP1-DBL1α amino acid motifs in severe disease states of Plasmodium falciparum malaria

TL;DR: It is suggested that certain PfEMP1 sequences are predisposed to inducing severe malaria through var-specific DBL1α-PCR amplification and sequencing.